Leerink Partnrs Has Optimistic Outlook of MIRM Q2 Earnings
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Stock analysts at Leerink Partnrs upped their Q2 2025 earnings per share (EPS) estimates for Mirum Pharmaceuticals in a research report issued on Wednesday, May 7th. Leerink Partnrs analyst M. Foroohar now expects that the company will post earnings of ($0.31) per share for the quarter, up […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Stock analysts at Leerink Partnrs upped their Q2 2025 earnings per share (EPS) estimates for Mirum Pharmaceuticals in a research report issued on Wednesday, May 7th. Leerink Partnrs analyst M. Foroohar now expects that the company will post earnings of ($0.31) per share for the quarter, up […]
